Transpara vs PowerLook Density Assessment
AI Verdict
Choose Transpara if…
Choose Transpara if your primary goal is to enhance breast cancer detection rates and optimize radiologist workflow for both 2D and 3D mammography. This tool offers AI-powered detection, temporal comparison with prior exams, and risk categorization, aiming to reduce workload while increasing cancer detection. It's particularly well-suited for practices seeking a comprehensive AI solution to act as a 'second pair of eyes' for radiologists, providing decision support and prioritizing high-risk cases.
View Transpara →Choose PowerLook Density Assessment if…
Choose PowerLook Density Assessment if your main objective is to standardize and automate breast density assessment using objective BI-RADS® 5th Edition categories. This tool excels at removing subjectivity from breast density reporting by analyzing digital mammograms for dense tissue area and dispersion. It is ideal for facilities that need consistent, accurate, and reproducible breast density assessments to personalize screening recommendations and comply with reporting standards.
View PowerLook Density Assessment →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Transpara | PowerLook Density Assessment |
|---|---|---|
| Pricing | Enterprise | Contact vendor for pricing. |
| Deployment | On premise | On-premise or integrated solution within existing radiology infrastructure (operates on iCAD's PowerLook® platform and PowerLook DICOM server platform). |
| FDA Status | Cleared AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TransparaTranspara offers a broader range of features beyond just density assessment, including AI-powered detection for 2D and 3D mammograms, temporal comparison, and risk categorization. This comprehensive suite of tools, designed to be a concurrent reading aid, suggests a more integrated and potentially more impactful workflow for radiologists compared to a standalone density assessment tool. PowerLook focuses solely on automated density assessment, which, while valuable, is a more limited scope.
Clinical Value
TransparaTranspara provides a more extensive set of clinical benefits, including earlier breast cancer detection, workflow optimization, and a high negative predictive value for low-risk cases (99.97%). While PowerLook's automated density assessment is clinically valuable for standardizing reporting and personalizing screening, Transpara's direct impact on detection and risk stratification offers a broader and potentially more critical clinical advantage in patient outcomes and radiologist efficiency.
Pricing & Value
TieBoth tools use an enterprise custom pricing model, requiring direct contact with the vendor for details. Without specific pricing information for either product, it's impossible to definitively compare their value propositions. Both offer significant clinical benefits, but their cost-effectiveness cannot be assessed from the available data.
Enterprise Readiness
TransparaTranspara demonstrates stronger enterprise readiness, serving 'hundreds of leading centers in 30+ countries' and analyzing 'over 11 million mammograms.' This extensive global adoption and proven track record indicate robust scalability and integration capabilities for large health systems. While PowerLook is also designed for integration within existing radiology infrastructure, Transpara's documented widespread deployment suggests a more mature and proven enterprise solution.
Innovation
TransparaTranspara showcases greater innovation by integrating multiple advanced AI features beyond basic detection, such as temporal comparison across six years of priors and comprehensive risk categorization. While PowerLook's multi-vendor deep learning algorithm for density assessment is innovative in its standardization, Transpara's broader application of AI to enhance detection, workflow, and risk assessment represents a more comprehensive and forward-thinking approach to breast imaging AI.
Support & Docs
TieNeither the provided facts nor general web searches offer specific details regarding the level of customer support, training, or documentation available for either Transpara or PowerLook Density Assessment. Both are enterprise-level solutions, implying professional support, but without explicit information, a definitive comparison is not possible.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Transpara | PowerLook Density Assessment |
|---|---|---|
| Name | Transpara | PowerLook Density Assessment |
| Company | ScreenPoint Medical B.V. | iCAD |
| Description | FDA-cleared AI solution that enhances breast cancer detection and optimizes radiologist workflow for 2D and 3D mammography. | Automated breast density software that analyzes digital mammograms to provide objective BI-RADSu00ae 5th Edition breast density categories, aiming to standardize assessments and personalize breast cancer screening. |
| Key Features | AI-powered detection for 2D and 3D mammograms (FFDM and DBT), Temporal Comparison, Breast Density assessment (BI-RADS-like and volumetric), Risk categorization (Elevated, Intermediate, Low), Region-based and overall exam scores, Workflow optimization and workload reduction, Concurrent reading aid for radiologists, High negative predictive value for low-risk cases (99.97%) | Automated breast density assessment, Analyzes digital mammograms for processing, Calculates dense tissue area and total breast area, Provides BI-RADSu00ae 5th Edition density category (a-d), Removes subjectivity in breast density reporting, Deep-learning AI multi-vendor solution, Integrates and automates breast density reporting within RIS/MIS, Compatible with Digital Breast Tomosynthesis (DBT) and synthetic 2D images |
| Specialties | Obstetrics & Gynecology, Radiology | Obstetrics & Gynecology, Oncology, Radiology |
| Target Size | Solo to large health systems | Not specified |
| Customer Count | Hundreds of leading centers in 30+ countries; over 11 million mammograms analyzed | Not specified |
Videos
Demos, reviews, and walkthroughs featuring Transpara and PowerLook Density Assessment.